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Aza-conjugate addition of the lithium anion of N-trimethylsilyl-p-methoxybenzylamine to tert-
butyl enoate acceptors, in the presence of a stoichiometric amount of enantiopure 1,2-
dimethoxy-1,2-diphenylethane and excess trimethylsilyl chloride, affords tert-butyl-N-p-
methoxybenzyl-β-amino esters with excellent levels of enantiocontrol. These N-p-
methoxybenzyl-β-amino-esters may be deprotected under oxidative conditions via treatment 
with ceric ammonium nitrate, followed by acid hydrolysis of the resultant imine intermediates, 
to afford enantiopure β-amino-esters containing hydrogenolytically sensitive functionality. 
2009 Elsevier Ltd. All rights reserved.
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1. Introduction 
Enantiomerically pure β-amino acids and their derivatives are 
important chiral building blocks for the synthesis of drug 
molecules and natural products.1 They are also useful as 
monomers for the preparation of biologically active β-peptides 
and αβ-peptides2 that are more resistant to proteolytic cleavage 
than peptides derived from α-amino acids.3 For example, β-
peptides have been reported that display antibiotic,4 antifungal,5 
antiviral,6 anticancer,7 and cholesterol uptake inhibitory 
activities.8 Relatively short β-peptides sequences are also known 
to display defined secondary structures,9 which enables 
foldameric β-peptides to be used to investigate medicinally 
relevant protein-protein interactions.10 However, the range of 
naturally occurring β-amino acid derivatives available from the 
chiral pool is limited, and as a consequence methodology is 
required for their preparation in enantiopure form.11 Effective 
strategies that currently exist, include those based on kinetic 
resolution,12 stereoselective addition of enolate equivalents to 
imines,13 Curtius rearrangement of chiral succinate derivatives,14 
Arndt-Eistert homologation of chiral α-amino acids,15 and 
hydrogenation/reduction of N-enamine and N-acyl-enamide 
derivatives.16 
One of the more popular strategies employed for the synthesis of 
enantiopure β-amino acid derivatives involves the stereoselective 
conjugate addition of aza-nucleophile equivalents to α-β-
unsaturated acid equivalents.17 Within this area, a range of highly 
effective protocols have been developed based on the 
stereoselective addition of lithium amides to enoate acceptors. 
For example, Yamamoto and coworkers have reported that 
achiral lithium N-trialkylsilylamides such as 1a add to chiral 
enoate acceptors that contain γ-stereocentres with good levels of 
diastereocontrol.18 Alternatively, Davies and coworkers have 
employed chiral lithium amides derived from α-
methylbenzylamine for the diastereoselective synthesis of an 
impressive number of β-amino esters.19 Tomioka and coworkers 
have developed an elegant external chiral ligand approach that 
enables achiral lithium amides to be used as aza-nucleophiles for 
the enantioselective synthesis of β-amino esters. They first 
reported that addition of lithium N-benzyl-N-
(trimethylsilyl)amide 1a to α,β-unsaturated esters 3 in the 
presence of a stoichiometric amount of the chelating C2-
symmetric ligand (R,R)-1,2-dimethoxy-1,2-diphenylethane 2, 
gave protodesilylated N-benzyl-β-amino esters 4 with excellent 
levels of enantiocontrol (e.g. 93% ee for 4a).20 These N-aryl-β-
amino esters could then be N-deprotected under hydrogenolytic 
conditions (Pd(OH)2/C, 7 atm. H2) to afford their parent β-amino 
esters 5a in good yield (Scheme 1a).20 This external chiral ligand 
controlled methodology has proven to be useful for the synthesis 
of a range of cyclic β-amino acid derivatives;21 and intermediates 
for the synthesis of the drugs otamixaban, premafloxacin,22 and 
the alkaloid natural products (−)-aspidospermidine,23 (−)-
kopsinine24 and (−)-lycorine.25 However, the hydrogenolysis 
conditions used to deprotect N-benzyl-β-amino esters 4a derived 
from cinnamate acceptors were reported to be problematic 
because these conditions resulted in competing cleavage of their 
β-nitrogen bonds to afford unwanted 3-arylpropanoates.26 In 
order to address this problem, Tomioka and coworkers 
introduced a range of lithium N-(trialkylsilyl)-amides 1b-d as 
second generation aza-nucleophiles for the enantioselective 
synthesis of N-protected-β-amino esters 4b-d with good levels of 
enantiocontrol (≥89% ee) (Schemes 1b-d).26,27 A range of 
different N-deprotection strategies were employed to deprotect 
these N-protected-β-amino esters 4 to afford their parent chiral 
NH-β-amino esters 5a in good yield. Chiral N-anthraceny-9-yl-β-
amino-esters 4b could be deprotected under milder 
hydrogenolytic conditions using H2 (1 atm) and 10% Pd/C over a 
period of 24 h (Scheme 1b).26 Chiral N-mesitylamine-β-amino-
esters 4c was deprotected through a three step N-
chlorination/regioselective dehydrochlorination/trans-oximation 
protocol (Scheme 1c);27a conditions that could also be used to 
deprotect N-benzyl-β-amino ester 4a.22 Alternatively, chiral N-
allyl-β-amino esters 4d was deprotected using a tandem rhodium 
catalysed isomerisation/imine hydrolysis approach (Scheme 
1d).27b Further to these reports, we now report that lithium N-p-
methoxybenzyl-N-(trimethylsilyl)amide 1e can also be used as an 
achiral aza-nucleophile in these type of chiral ligand mediated 
aza-conjugate addition reactions to afford chiral N-p-
methoxybenzyl β-amino-esters 6 with excellent levels of 
enantiocontrol. The p-methoxybenzyl (PMB) fragments of these 
N-PMB-β-amino esters 6 may then be oxidatively deprotected 
using ceric ammonium nitrate (CAN) to afford chiral NH-β-
amino esters 5 that can contain hydrogenolytically sensitive 
functionality (Scheme 1e). 
Scheme 1: Tomioka’s external chiral ligand 2 methodology for the 
enantioselective synthesis of β-amino esters 5. 
2. Results and Discussion 
As part of a research program directed towards the asymmetric 
synthesis of β-amino acids28 as chiral precursors for the synthesis 
of novel heterocyclic scaffolds, we required access to a range of 
β-amino esters containing hydrogenolytically sensitive 
functionality. Davies and coworkers had previously reported the 
use of lithium N-benzyl-N-α-methyl-p-methoxybenzylamide 7 as 
a chiral aza-nucleophile for the diastereoselective synthesis of 
chiral haloaryl-β-amino esters such as 8,29 whose N-benzyl and 
N-PMB protecting groups could be removed under oxidative 
conditions via stepwise treatment with excess CAN (Scheme 
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2a).30 This enabled lithium amide 7 (or its enantiomer) to be used 
for the asymmetric syntheses of a range of hydrogenolytically 
sensitive haloaryl and pyridinyl containing β-amino-acids, β-
lactams and heterocycles with good levels of stereocontrol.29,31 
Given this precedent, we reasoned that lithium N-(4-
methoxybenzyl-1,1,1-trimethyl-silanamide 1e might be useful as 
an aza-nucleophile for Tomioka’s chiral ligand conjugate 
addition methodology, since it would enable the N-PMB groups 
of its corresponding β-amino-ester adducts 6 to be removed using 
CAN under oxidative conditions (Scheme 1e).  
Tomioka and coworkers previously attempted to employ lithium 
amide 1e as an aza-nucleophile using their standard conditions (3 
eq. amide, 3.6 eq. chiral ligand 2, toluene, -78 °C), but reported 
that it was unsuccessful in delivering any chiral β-amino ester 
product (Scheme 2b), even when more forcing conditions were 
employed.26 However, we noticed that they had reported that 
addition of an excess of trimethylsilyl chloride (TMSCl) had the 
potential to improve both the yield and stereoselectivity of these 
types of aza-conjugate addition reactions. For example, reaction 
of 1.5 equivalents of lithium amide 1a with tert-butyl-cinnamate 
3a and 1.8 equivalents of ligand 2 in toluene at -78 °C afforded 
N-benzyl-β-amino ester 4a in 81% yield and 82% ee, which 
could be improved to 97% yield and 97% ee in the presence of 
5.0 equivalents of TMSCl (Scheme 2c).20 Consequently, we 
decided to investigate whether carrying out aza-conjugate 
addition reactions of lithium amide 1e with 3a in the presence of 
excess TMSCl might afford chiral N-PMB-β-amino-esters 6 in 
good yield and high ee. 
Scheme 2: A range of successful and unsuccessful aza-conjugate addition 
reactions that have been investigated for synthesis of β-amino esters 4a and 8. 
N-Trimethylsilyl-p-methoxybenzylamine 9 was first prepared 
by treating p-methoxybenzylamine with n-butyllithium in THF at       
0 °C, followed by addition of TMSCl and heating at reflux for 12 
hours. Its corresponding lithium amide 1e was then generated via 
treatment of 1.5 equivalents of amine 9 with n-butyllithium in 
toluene at -78 °C. A solution of 1.8 equivalents of chiral ligand 2 
in toluene was then added to this solution of lithium amide 1e in 
toluene at -78 °C, followed by further addition of a solution of 
tert-butyl-cinnamate 3a in toluene at -78 °C. The reaction was 
then stirred for 5 h before work-up at -78 °C using NH4Cl(aq). 
Promisingly, and in contrast to Tomioka’s previous report that no 
aza-conjugate addition reaction occurred,26 this reaction produced 
some of the desired protodesilylated N-PMB-β-amino ester 6a, 
albeit in low 35% yield and poor enantioselectivity (25% ee) 
(Scheme 3a). Encouraged by this result, we repeated this aza-
conjugate reaction under identical conditions, except that we 
employed a solution of tert-butyl-cinnamate and 5.0 equivalents 
of TMSCl in the final addition step. To our delight, the presence 
of excess TMSCl resulted in formation of the desired (R)-N-
PMB-β-amino ester 6a in a much improved 77% yield and 95% 
ee (Scheme 3b). 
Scheme 3: Chiral ligand 2 mediated aza-conjugate addition reaction of 
lithium amide 1e to tert-butyl enoate 3a in the presence of excess TMSCl 
affords β-amino ester 6a in good yield and high ee. 
The scope and limitation of this aza-conjugate addition reaction 
was then investigated by reacting lithium amide 1e with a range 
of α,β-unsaturated tert-butyl enoates 3b-h in the presence of 
excess TMSCl, including some substrates that contained 
hydrogenolytically sensitive functionality (Table 1). Therefore, 
tert-butyl cinnamate ester substrates containing halo-aryl 3b-c 
and cyano-aryl substituents 3d afforded their corresponding β-
amino esters 6b-d in good yields (62-79%) and with 95% ee 
(Table 1, Entries 2-4). However, (E)-tert-butyl 3-(4-
nitrophenyl)acrylate 3e proved less reactive, affording N-PMB-β-
amino ester 6e in only 40% yield and 95% ee (Table 1, Entry 5), 
with the poor yield being due to the presence of unreacted tert-
butyl enoate 3e. Aza-conjugate addition reactions of heteroatom 
containing tert-butyl enoates were also successful, with (E)-tert-
butyl 3-(thiophen-2-yl)acrylate 3f and (E)-tert-butyl 3-(furan-2-
yl)acrylate 3g affording their corresponding β-amino esters 6f 
(95% ee) and 6g (95% ee) in 86% and 73% yield respectively 
(Table 1, Entries 6-7). Finally, it was shown that the simple 
acyclic (E)-tert-butyl hept-2-enoate 3h afforded its corresponding 
N-PMB-β-amino ester 6h in 68% yield and 95% ee.  
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Table 1: Substrate scope of chiral ligand mediated aza-conjugate addition 
reactions of lithium amide 1e to α,β-unsaturated ester derivatives 3a-h. 
 
a. See experimental section for syntheses of tert-butyl enoates 3; b. Isolated 
yields of N-PMB-β-amino esters 6a-h after purification by chromatography; 
c. Ee’s of N-PMB-β-amino-esters 6a-h inferred from ee values subsequently 
determined for their parent N-deprotected β-amino esters 5a-h (vide infra); d. 
Error limit of ±3% ee arising from detection limit of the 1H NMR chiral 
derivatisation protocol used to determine the ee’s of β-amino esters 5a-h; e. 
Low yield of N-benzyl-β-amino ester 6e due to poor conversion, with 
significant amounts of unreacted tert-butyl enoate 3e present in the 1H NMR 
spectrum of the crude reaction product. 
Tomioka and coworkers have recently employed 6Li NMR 
spectroscopy to demonstrate that addition of chiral ligand 2 to 
lithium amide 1e initially results in formation of a mixture of cis- 
and trans- cyclic heterodimeric complexes (only cis-dimer 10 
shown in Figure 1).32 They proposed that addition of tert-butyl 
enoate 3 results in dissociation of these heterodimeric complexes 
to afford a new monomeric complex 11 containing one 
equivalent of lithium amide, one equivalent of chiral ligand and 
one equivalent of enoate. Intramolecular transfer of the amide 
fragment of complex 11 to its enoate fragment then occurs in a 
highly enantiofacial manner to afford a (Z)-enolate 12 that is then 
protonated on work-up with NH4Cl(aq) to afford the desired N-
PMB-β-amino ester 6 (Figure 1). The role of TMSCl in 
improving the yield and enantioselectivity of these type of aza-
conjugate addition reactions is unclear, however it is possible that 
it acts as an electrophilic O-silylating agent to trap out (Z)-
enolate 12 as its corresponding (Z)-silyl-ketene acetal 13 in situ. 
This would perturb the equilibria of the potentially reversible 
intramolecular aza-conjugate addition step (11 12), by 
preventing the reverse E1cB-elimination reaction of (Z)-enolate 
12 from occurring. Furthermore, it has been shown that enolates 
such as 12 can react with lithium amide complexes of ligand 2 to 
afford competing dimeric lithium complexes such as 14,33 which 
could potentially be responsible for competing non-
stereoselective aza-conjugate addition pathways that afford N-
PMB-β-amino ester 6 with poorer levels of control in the absence 
of TMSCl. Therefore, we propose that the presence of excess 
TMSCl ensures that (Z)-enolate 12 is rapidly trapped out as its O-
silyl ketene acetal 13,34 which ensures that the concentration of 
free enolate 12 remains sufficiently low to ensure that the 
enantioselective pathway to N-PMB-β-amino ester 6 
predominates (Figure 1). 
Figure 1: Potential role of TMSCl in improving yields and 
enantioselectivities of chiral ligand 2 mediated aza-conjugate addition 
reactions of lithium amide 1e with tert-butyl enoates 3. 
Having successfully identified conditions that enabled lithium 
amide 1e to be used as an effective aza-nucleophile for the 
enantioselective synthesis of N-PMB-β-amino esters 6a-h, we 
next investigated their N-deprotection under oxidative conditions. 
Treatment of N-PMB-β-amino ester 6a with 4.0 equivalents of 
CAN in MeCN/H2O (5:1) solution, followed by basic work up 
using NaHCO3(aq),29 afforded N-PMB-imine 15a in essentially 
quantitative yield (Scheme 4). A plausible mechanism for this 
CAN mediated oxidative N-deprotection step is presented in 
Scheme 4, whereby CAN first acts an electron acceptor from the 
p-methoxyphenyl (PMP) group to afford a stabilised radical 
Entry Enoate 
3a 
R Ν-PMB-β-
Amino Ester 
6a-h 
Yield 
(%)b 
ee 
(%)c,d 
1 3a 
 
6a 77 95 
2 3b 
 
6b 79 95 
3 3c 
 
6c 76 95 
4 3d 
 
6d 62 95 
5 3e 
 
6e 40e 95 
6 3f 
 
6f 86 95 
7 3g 
 
6g 73 95 
8 
 
3h 
 
6h 68 95 
Ph Ph
MeO OMe
N
Li
TMS
Toluene
-78 °C, 30 min
10
N
Li Li
N
TMS PMB
TMS PMB
OO
O O
HPh Ph
Ph
H
Ph
Me
Me
H
H
Me
Me
O
Ot-BuR
Toluene, -78 °C, 5 h
OTMS
Ot-BuR
N
TMS
TMSCl
11
13
Ph
Ph
O
O Li
Me
MeN
PMP
TMS
O
Ot-Bu
R
2
Ot-BuR
N
TMS
OLi
Enolate-amide-ligand
ternary complex 14
Fast and
irreversible
Competing aza-conjugate
addition pathway that occurs
with poor stereocontrol
MeO
Enolate 12
PMP
Ot-BuR
NH OPMP
No TMSCl
O
Ot-BuR
NHPMP
Good
Enantioselectivity
Poor ee
PMP
Protodesilylation during
reaction work-up
High ee
1e
126
6
Enolate 12
No TMSCl
3
slow
Li
N
Li
O
SiMe3
t-BuO
R
O
O
Ph
Ph
PMP
N
TMS
PMP
O
tBuO
R
Me
Me
LiCl
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cation 16. A benzylic proton of 16 is then deprotonated by water 
to afford a stabilized benzylic radical resonance form 17. A 
second equivalent of CAN then oxidises radical 17 to afford 
benzylic cation 18 which is resonance stabilized as its iminium 
species 19 that is subsequently isolated as imine 15a after basic 
workup. After a short optimisation screen of solvents, acids and 
reaction time, it was found that stirring a solution of N-PMB-
imine 15a in MeCN/H2O (5:1) in the presence of 15 eq. of acetic 
acid at room temperature for 48 h followed by neutralisation with 
NaHCO3(aq) and purification by chromatography, furnished (R)-
β-amino-tert-butyl ester 5a in 83% yield and 95% ee. The (R)- 
configuration and 95% ee of (R)-β-amino-tert-butyl ester 5a was 
confirmed by comparison of the sign and magnitude of its 
specific rotation of (R)-N-benzyl-β-amino of [α] +20.0 (c 1.2, 
CHCl3), with the literature value of [α]+19.7 (c 0.96, CHCl3).29 
 
Scheme 4: CAN mediated oxidative N-deprotection of N-PMB-β-amino ester 
6a to afford an intermediate imine 15a that is then hydrolysed under aqueous 
acidic conditions to afford β-amino ester 5a. 
This oxidative N-deprotection methodology was then applied to 
unmask the remaining N-PMB-β-amino esters 6b-h to afford 
their corresponding deprotected NH-β-amino esters 5b-h in 
moderate to good yields (36-73%) over two steps (Table 2). It 
was found that the <60% yields obtained for formation of NH-β-
amino esters 5b, 5e and 5f (Entries 2, 4 and 6) were due to 
competing acid catalysed cleavage of their tert-butyl ester 
fragments to afford their corresponding acids in the imine 
hydrolysis step. Evidence for this competing tert-butyl cleavage 
pathway was obtained from 1H NMR spectroscopic and mass 
spectrometric analysis of the aqueous washings of the crude 
reaction products of the imine hydrolysis reactions, which clearly 
revealed the presence of their corresponding β-amino acids.35 
The enantiomeric excesses of β-amino esters 5a-h were 
confirmed as 95% ee using a simple three-component chiral 
derivatisation protocol previously developed in our research 
group.36 In this approach, a chiral amine of unknown 
enantiomeric excess is derivatised with 2-formylphenyl boronic 
acid and enantiopure BINOL to afford a mixture of 
diastereomeric imino-boronate  
 
 
Table 2: CAN deprotection reactions of N-PMB-β-amino esters. 
 
Entry Ν-PMB-β-
Amino Ester 
 6a-h 
R β-Amino 
Ester  
5a-h 
Yiel
d 
(%)a 
ee 
(%)c,d 
1 6a 
 
5a 68 95 
2 6b 
 
5b 56 b 95 
3 6c 
 
5c 68 95 
4 6d 
 
5d 51b 95 
5 6e 
 
5e 65 95 
6 6f 
 
5f 36b 95 
    7 6g 
 
5g 73 95 
8 6h 
 
5h 60 95 
a. Isolated yields of β-amino esters 5a-h after purification by 
chromatography; b. Lower yields of β-amino esters due to competing 
cleavage of their tert-butyl ester fragments in the imine hydrolysis step to 
give their corresponding β-amino acids; c. Ee’s determined by derivatisation 
of β-amino esters 5a-h with 2-formylphenylboronic acid and (R)-BINOL 
followed by 1H NMR spectroscopic analysis of the ratio of the resultant 
mixture of diastereomeric imino-boronate esters;36 d. Error limit of ±3% in ee 
arising from the detection limit of the 1H NMR chiral derivatisation protocol. 
esters whose ratio can be determined by 1H NMR spectroscopic 
analysis. Since no kinetic resolution occurs in this derivatisation 
process, this diasteromeric ratio corresponds to the enantiomeric 
ratio of the parent chiral amine. For example, β-amino ester (R)-
5a was first derivatised via treatment with 2-
formylphenylboronic acid 20, (rac)-BINOL, and K2CO3 in 
CDCl3 for 10 min to afford a 50:50 mixture of the diastereomeric 
iminoboronate esters (RBIN,R)-21 and (SBIN,R)-22 (Scheme 5a). 
Analysis of the 1H NMR spectrum of this mixture revealed well 
resolved resonances corresponding to the diastereotopic 
methylene and tert-butyl ester protons of the (RBIN,R)-21 (CHA, 
CHA’ and CHB3) and (SBIN,R)-22 (CHC, CHC’ and CHD3) 
diastereomers respectively (∆δH = 0.1-0.4 ppm), whose integrals 
could be used to accurately determine their diastereomeric ratio 
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(Figure 2a). A sample of β-amino ester (R)-5a generated using 
our enantioselective aza-conjugate addition protocol, was then 
derivatised with 2-formylphenylboronic acid 20 and enantiopure 
(R)-BINOL, with 1H NMR spectroscopic analysis revealing that 
(RBIN,R)-21 and (RBIN,S)-22 were present in a diastereomeric ratio 
of 97.5:2.5 (Scheme 5b). This ratio was accurately determined by 
comparison of the integral ratios of the well resolved tert-butyl 
proton singlet resonances of (RBIN,R)-21 (O(CHB3) and (RBIN,S)-22 
(O(CHD3) at δ0.85 ppm and δ1.15  respectively (Figure 2b). 
Therefore, since no kinetic resolution occur in the derivatisation 
process, it follows that this 97.5:2.5 diasteromeric ratio 
corresponds to the enantiomeric ratio of chiral amine 5a, thus 
allowing us to conclude that it had been formed in 95% ee. 
Scheme 5: Chiral derivatisation protocol used to determine the enantiopurity 
of β-amino ester 5a as 95% ee. 
 
Figure 2. a) 1H NMR spectrum of 50:50 mixture of diastereomeric 
iminoboronate ester complexes (RBIN,R)-21 and (SBIN,R)-22. b) 1H NMR 
spectrum of a 97.5:2.5 mixture of diastereomeric iminoboronate ester 
complexes (RBIN,R)-21 and (RBIN,S)-22. 
3. Conclusions 
Aza-conjugate addition of lithium amide 1e to tert-butyl enoates, 
in the presence of a stoichiometric amount of an external chiral 
ligand 2 and excess trimethylsilyl chloride, affords tert-butyl N-
PMB-β-amino esters 6a-h with excellent levels of enantiocontrol. 
The resultant tert-butyl N-PMB-β-amino esters 6a-h may be 
deprotected via treatment with CAN, followed by acid hydrolysis 
of their resultant imine intermediates, to afford their parent chiral 
β-amino-esters 5a-h (95% ee). The ability to deprotect N-PMB-
β-amino esters 6 under oxidative conditions enables this second 
generation variant of Tomioka’s external chiral ligand mediated 
lithium amide methodology to be used for the enantioselective 
synthesis of β-amino esters 6 that contain functionalities that are 
susceptible to hydrogenolysis. 
4. Experimental 
General methods 
Reactions that required the use of dry solvents were conducted in 
oven dried glassware under an atmosphere of nitrogen using inert 
atmosphere techniques. Dry solvents were obtained by passing 
them through anhydrous alumina columns using an Innovative 
Technology Inc. PS-400-7 solvent purification system. Petrol 
refers to the fraction of petroleum ether boiling at 40-60 °C. 
Hexanes refers to the hexane fraction of petroleum. Solvents 
were evaporated on a Büchi Rotorvapor. All commercially 
available compounds were used as obtained from chemical 
suppliers. 1H and 13C NMR spectra were run in CDCl3 using 
Bruker Avance 250/300/400/500 MHz spectrometers. Chemical 
shifts (δ) are quoted in parts per million and are referenced to the 
residual solvent peak. Coupling constants (J) are quoted to the 
nearest 0.1 Hz. Infra-red spectra were recorded on a Perkin Elmer 
Spectrum 100 FT-IR spectrometer, using a Universal ATR 
accessory for sampling, with only selected absorbances quoted as 
ν in cm-1. Mass spectra were recorded on a micrOTOF 
electrospray time-of-flight (ESI-TOF) mass spectrometer (Bruker 
Daltonik GmbH, Bremen, Germany), using acetonitrile or water 
to dissolve the sample. TLC was carried out using commercially 
available polyethylene backed plates coated with Merck 
Kieselgel 60 GF254. Plates were visualised under UV light (at 
254 nm) or by staining with potassium permanganate, ninhydrin 
or phosphomolybdic acid followed by gentle heating. Flash 
chromatography was performed under manually generated 
medium pressure using Merck 60 H silica gel (35-75 µm) unless 
otherwise stated.  
(R,R)-1,2-Dimethoxy-1,2-diphenylethane 2 
(R,R)-Hydrobenzoin (1.00 g, 4.67 mmol) was added dropwise (5 
min) to a stirred refluxing suspension of sodium hydride (60% 
dispersion, 0.467 g, 11.7 mmol) in dry THF (10 mL). This 
mixture was heated at reflux for a further 30 minutes and then 
cooled to 0 °C prior to the addition of methyl iodide (15.0 mL, 
100 mmol). The reaction was then stirred at room temperature 
overnight, whereupon TLC analysis showed consumption of the 
starting material. The mixture was cooled to 0 °C and quenched 
with water (10 mL), extracted with EtOAc (3 x 50 mL), washed 
with brine, dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. The residue was recrystallised from 
hexane/Et2O to afford the title compound as a white crystalline 
solid (0.68 g, 60%). [α]-15.1 (c 1.8, CHCl3) (Lit.37 [α] -15.2 
(c 2.1, CHCl3); 1H NMR (300 MHz, CDCl3) δH = 7.23-7.15 (6H, 
m, Ph), 7.08-6.98 (4H, m, Ph), 4.34 (2H, s, CHOCH3), 3.30 (6H, 
s, OCH3); 13C NMR (75 MHz, CDCl3) δC = 138.2, 127.9, 127.8, 
127.6, 87.7, 57.2; IR (thin film) υmax (cm-1): 1492 (w, C=C), 
1455 (w, C=C); HRMS (ESI): m/z 265.1188, C16H18NaO2 
[M+Na]+ requires 265.1199.  
N-(4-Methoxybenzyl)-1,1,1-trimethylsilanamine 9  
n-Butyllithium solution (2.3 M in hexanes, 6.6 mL, 38.2 mmol) 
was added to a stirred solution of para-methoxybenzylamine 
(5.00 g, 36.4 mmol) in THF (140 mL) at 0 °C. The reaction was 
stirred at room temperature for 8 hours before being cooled to 0 
°C and a solution of addition of TMSCl (4.67 mL, 36.8 mmol) in 
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THF (40 mL) added dropwise. The reaction was heated at reflux 
for 12 hours, concentrated, triturated with pentane (2 x 100 mL) 
and solvent removed in vacuo to afford the title compound as a 
yellow oil (5.59 g, 73% yield). 1H NMR (300 MHz, CDCl3) δH = 
7.16 (2H, d, J = 8.6 Hz, CH3OCCHCH), 6.82 (2H, d, J = 8.6 Hz, 
CH3OCCH), 3.77 (2H, d, J = 7.8 Hz, CH2N), 3.7 (3H, s, OCH3), 
1.90 (1H, br. s, NH), 0.00 (9H, s, Si(CH3)3); 13C NMR (75 MHz, 
CDCl3) δC = 158.2, 136.5, 129.1, 113.85, 55.2, 45.3, 0.0; IR (thin 
film) υmax (cm-1): 3305 (w, NH), 1505, 1499 (m, m, C=C). 
 
(E)-tert-Butyl 3-phenylacrylate 3a 
A solution of iodobenzene (2.69 g, 13.2 mmol) 
diisopropylethylamine (6.90 mL, 39.6 mmol), tert-butyl acrylate 
(2.12 mL, 14.5 mmol), tri(o-tolyl)phosphine (0.40 g, 13.2 mmol) 
and palladium(II) acetate (0.15 g, 0.66 mmol) in MeCN (80 mL) 
was heated at reflux for 17 hours. The suspension was then 
cooled to room temperature, diluted with water (60 mL) and 
extracted with EtOAc (3 x 50 mL). The combined organic 
extracts were washed with brine and water, dried over anhydrous 
MgSO4 and concentrated in vacuo. The residue was purified by 
flash chromatography (EtOAc-petrol, 1:30) to afford the title 
compound as a yellow oil (1.94 g, 72% yield). 1H NMR (300 
MHz, CDCl3) δH = 7.51 (1H, d , J = 16.0 Hz, CH=CHCO2), 7.47-
7.25 (5H, m, Ph), 6.30 (1H, d, J = 16.0 Hz, CH=CHCO2), 1.46 
(9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 166.3, 143.6, 
134.7, 123.0, 128.8, 128.0, 120.2, 80.5, 28.2; IR (thin film) υmax 
(cm-1): 1703 (s, C=O); HRMS (ESI): m/z 227.1025, C13H16NaO2 
[M+Na]+ requires 227.1043. 
 
General Procedure 1: Synthesis of tert-butyl enoates 3b-g.  
Methylmagnesium bromide (1 eq.) was added to a solution of 
tert-butyl 2-(diethoxyphosphoryl)acetate (1 eq.) in dry THF (0.1 
M) at room temperature under an inert atmosphere and the 
mixture stirred for 15 minutes. A dry THF (0.2 M) solution of the 
appropriate aryl aldehyde (1 eq) was then added dropwise (5 
min) and the reaction mixture heated at reflux for 18 hours. After 
cooling to room temperature, saturated NH4Cl(aq) was added and 
the mixture extracted with Et2O (3 x 30 mL). The combined 
organic extracts were washed with brine and water, dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. The 
residue was then purified by silica gel chromatography (EtOAc-
petrol, 1:30) to afford the desired tert-butyl enoate 3. 
 
(E)-tert-Butyl 3-(4-bromophenyl)acrylate 3b 
4-Bromobenzaldehyde (0.36 g, 2 mmol) was used to prepare the 
title compound as a white solid (0.404 g, 72% yield) using 
general procedure 1. Mp. 53-55 °C; 1H NMR (300 MHz, CDCl3) 
δH = 7.47 (1H, d, J = 15.8 Hz, CH=CH O2), 7.42 (2H, d, J = 6.8 
Hz, BrCCHCH), 7.29 (2H, d, J = 6.8 Hz, BrCCHCH), 6.31 (1H, 
d, J = 15.8 Hz, CH=CHCO2), 1.46 (9H, s, C(CH3)3); 13C NMR 
(75 MHz, CDCl3) δC = 166.1, 142.2, 133.6, 132.1, 129.36, 124.2, 
120.9, 80.8, 28.2; IR (thin film) υmax (cm-1): 1704 (s, C=O); 
HRMS (ESI): m/z 305.0129, C13H15BrNaO2 [M+Na]+ requires 
305.0153. 
 
(E)-tert-Butyl 3-(2,4-dichlorophenyl)acrylate 3c 
2,4-Dichlorobenzaldehyde (0.52 g, 3 mmol) was used to prepare 
the title compound as a colourless oil (0.59 g, 78% yield) using 
general procedure 1. 1H NMR (300 MHz, CDCl3) δH = 7.92 (1H, 
d, J = 16.0 Hz, CH=CHCO2), 7.54 (1H, d, J = 8.5 Hz, CHCCl), 
7.43 (1H, d, J = 2.0 Hz, CClCHCCl), 7.25 (1H, dd, J = 8.6 and 
2.0 Hz, CCHCH), 6.35 (1H, d, J = 16.1 Hz, CH=CHCO2), 1.54 
(9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 165.6, 138.1, 
136.0, 135.4, 131.5, 129.9, 128.3, 127.5, 123.2, 81.0, 28.2; IR 
(thin film) υmax (cm-1): 1706 (s, C=O); HRMS (ESI): m/z 
295.0244, C13H14Cl2NaO2 [M+Na]+ requires 295.0269. 
 
(E)-tert-Butyl 3-(4-cyanophenyl)acrylate 3d 
4-Formylbenzonitrile (0.39 g, 3 mmol) was used to prepare the 
title compound as a white solid (0.59 g, 82% yield) using general 
procedure 1. Mp. 140-142 °C; 1H NMR (300 MHz, CDCl3) δH = 
7.67 (2H, d, J = 7.6 Hz, NCCCH), 7.58 (2H, d, J = 7.6 Hz, 
NCCCHCH), 7.55 (1H, d, J = 16.1 Hz, CH=CHCO2), 6.45 (1H, 
d, J = 16.1 Hz, CH=CHCO2), 1.54 (9H, s, C(CH3)3); 13C NMR 
(75 MHz, CDCl3) δC = 165.4, 141.1, 139.0, 132.6, 128.3, 123.8, 
118.4, 113.1, 81.2, 28.1; IR (thin film) υmax (cm-1): 2226 (m, CN), 
1702 (s, C=O); HRMS (ESI): m/z 252.0990, C14H15NNaO2 
[M+Na]+ requires 252.1000. 
 
(E)-tert-Butyl 3-(4-nitrophenyl)acrylate 3e 
4-Nitrobenzaldehyde (0.30 g, 2 mmol) was used to prepare the 
title compound as a colourless oil (0.35 g, 70% yield) using 
general procedure 1. 1H NMR (300 MHz, CDCl3) δH = 8.14 (2H, 
d, J = 8.7 Hz, O2NCCH), 7.57 (2H, d, J = 8.7 Hz, O2NCCHCH), 
7.53 (1H, d, J = 16.0 Hz, CH=CHCO2), 6.42 (1H, d, J = 15.9 Hz, 
CH=CHCO2), 1.46 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) 
δC = 165.3, 148.3, 140.9, 140.6, 128.5, 124.5, 124.1, 81.5, 28.1; 
IR (thin film) υmax (cm-1): 1708 (s, C=O); HRMS (ESI): m/z 
272.0878, C13H15NNaO4 [M+Na]+ requires 272.0899. 
 
(E)-tert-Butyl 3-(thiophen-2-yl)acrylate 3f 
Thiophene-2-carboxaldehyde (0.44 g, 4 mmol) was used to 
prepare the title compound as a colourless oil (0.60 g, 71% yield) 
using general procedure 1. 1H NMR (300 MHz, CDCl3) δH = 7.67 
(1H, d, J = 15.7 Hz, CH=CHCO2), 7.32 (1H, d, J = 5.1 Hz, 
CHS), 7.20 (1H, d, J = 3.5 Hz, CHCS), 7.02 (1H, dd, J = 5.1 and 
3.6 Hz, CHCHCHS), 6.16 (1H, d, J = 15.7 Hz, CH=CHCO2), 
1.51 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 166.2, 
139.8, 136.1, 130.5, 128.0, 119.0, 80.5, 28.2; IR (thin film) υmax 
(cm-1): 1699 (s, C=O); HRMS (ESI): m/z 233.0591, C11H14NaO2S 
[M+Na]+ requires 233.0612. 
 
(E)-tert-Butyl 3-(furan-2-yl)acrylate 3g 
Furan-2-carboxaldehyde (0.48 g, 5 mmol) was used to prepare 
the title compound as a yellow oil (0.52 g, 65% yield) using 
general procedure 1. 1H NMR (300 MHz, CDCl3) δH = 7.38 (1H, 
d, J = 1.6 Hz, CHO), 7.26 (1H, d, J = 15.9 Hz, CH=CHCO2), 
6.50 (1H, d, J = 3.4 Hz, CHCO), 6.38 (1H, dd, J = 3.4 and 1.8 
Hz, CHCHCHO), 6.18 (1H, d, J = 15.9 Hz, CH=CHCO2), 1.44 
(9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 166.4, 151.2, 
144.4, 130.1, 118.0, 114.0, 112.1, 80.4, 28.2; IR (thin film) υmax 
(cm-1): 1701 (s, C=O); HRMS (ESI): m/z 217.0875, C11H14NaO3 
[M+Na]+ requires 217.0841. 
 
(E)-tert-Butyl hept-2-enoate 3h 
tert-Butyl acrylate (5.92 mL, 40.8 mmol) and Grubbs 2nd 
generation catalyst (0.10 g) were added to a solution of hex-1-ene 
(2.89 mL, 13.6 mmol) in CH2Cl2 (29 mL) under an inert 
atmosphere. The reaction mixture was stirred at room 
temperature for 24 hours and then filtered through celite and 
concentrated in vacuo. Distillation of the residue afforded the 
title compound as a colourless oil (1.42 g, 55% yield). Bp. 90 °C 
@ 0.8 Torr; 1H NMR (250 MHz, CDCl3) δH = 6.78 (1H, dt, J = 
15.7 and 6.9 Hz, CH2CH=CH), 5.66 (1H, dt, J = 15.7 and 1.5 Hz, 
CH2CH=CH), 2.10 (2H, qd, J = 7.1 and 1.5 Hz, CH2-CH2-CH), 
1.49 (9H, s, C(CH3)3), 1.37-1.18 (4H, m, CH3CH2CH2), 0.93 (3H, 
t, J = 7.1 Hz, CH3CH2); 13C NMR (75 MHz, CDCl3) δC = 166.6, 
148.5, 123.3, 80.3, 32.2, 30.6, 28.5, 22.6, 14.2; IR (thin film) υmax 
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(cm-1): 1706 (s, C=O); HRMS (ESI): m/z 207.1343, 
C11H20NaO2 [M+Na]+ requires 207.1361. 
 
General Procedure 2: Enantioselective Synthesis of N-p-
methoxybenyl-β-amino esters 6a-h. 
n-Butyllithium (2.5 M in hexanes, 1.5 eq.) was added dropwise 
(5 min) to a solution of N-(4-methoxybenzyl)-1,1,1-trimethyl-
silanamine 9 (1.5 eq.) in dry toluene (0.33 M) at -78 °C. After 
stirring the mixture at -78 °C for 30 minutes, a solution of chiral 
ligand 2 (1.8 eq.) in dry toluene (1 M) was added dropwise (5 
min). After stirring the mixture for a further 30 minutes at -78 °C, 
a solution of the appropriate tert-butyl ester 1 (1 eq.) and TMSCl 
(5 eq.) in dry toluene (2 M) was then added dropwise (5 min). 
The reaction mixture was stirred for 5 hours at -78 °C and then 
quenched via the careful addition of saturated NH4Cl(aq). After 
allowing the suspension to stir and warm to room temperature, 
saturated NaHCO3(aq) was added carefully and extracted with 
EtOAc (3 x 100 mL). The combined organic extracts were 
washed with brine and water, dried over anhydrous MgSO4, 
filtered and concentrated in vacuo and then purified by silica gel 
chromatography to afford the desired N-PMB-β-amino ester 6a-
h. 
 
(R)-tert-Butyl 3-((4-methoxybenzyl)amino)-3-phenylpropanoate 
6a 
(E)-tert-Butyl 3-phenylacrylate 1a (1.18 g, 5.8 mmol) was used 
to prepare the title compound as a yellow oil (1.52 g, 77% yield) 
using general procedure 2. []	
 +25.9 (c 3.2, CH2Cl2); 1H NMR 
(300 MHz, CDCl3) δH = 7.43-7.26 (5H, m, Ph), 7.22 (2H, d, J = 
8.6 Hz, CHCHCOCH3), 6.87 (2H, d, J = 8.6 Hz, CHCHCOCH3), 
4.09 (1H, dd, J = 8.6 and 5.5 Hz, CHNH), 3.82 (3H, s, OCH3), 
3.61 (1H, d, J = 12.9 Hz, NHCHAHB), 3.51 (1H, d, J = 12.9 Hz, 
NHCHAHB), 2.68 (1H, dd, J = 15.3 and 8.7 Hz, CHACHBCO2), 
2.56 (1H, dd, J = 15.3 and 5.6 Hz, CHACHBCO2), 2.20 (1H, br. s, 
NH), 1.40 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 
171.1, 158.6, 142.8, 132.6, 129.3, 128.5, 127.4, 113.8, 80.6, 59.1, 
55.3, 50.8, 44.3, 28.0; IR (thin film) υmax (cm-1): 1721 (s, C=O); 
HRMS (ESI): m/z 364.1911,
 
C21H27NNaO3 [M+Na]+ requires 
364.1889. 
 
(R)-tert-Butyl 3-(4-bromophenyl)-3-((4-methoxybenzyl)amino)-
propanoate 6b 
(E)-tert-Butyl 3-(4-bromophenyl)acrylate 1b (0.55 g, 1.95 mmol) 
was used to prepare the title compound as a white solid (0.64 g, 
79% yield) using general procedure 2. []	
 +38.6 (c 1.71, 
EtOAc); 1H NMR (300 MHz, CDCl3) δH = 7.40 (2H, d, J = 8.3 
Hz, CHCHCBr), 7.18 (2H, d, J = 8.3 Hz, CHCHCBr), 7.09 (2H, 
d, J = 8.5 Hz, CHCHCOCH3), 6.77 (2H, d, J = 8.5 Hz, 
CHCHCOCH3), 3.95 (1H, dd, J = 8.4 and 5.4 Hz, CHNH), 3.72 
(3H, s, OCH3), 3.48 (1H, d, J = 12.5 Hz, NHCHAHB), 3.38 (1H, 
d, J = 12.5 Hz, NHCHAHB), 2.52 (1H, dd, J = 15.4 and 8.4 Hz, 
CHACHBCO2), 2.40 (1H, dd, J = 15.4 and 5.4 Hz, CHACHBCO2), 
1.94 (1H, br. s, NH), 1.30 (9H, s, C(CH3)3); 13C NMR (75 MHz, 
CDCl3) δC = 170.8, 158.6, 141.8, 132.2, 131.6, 129.3, 129.1, 
121.1, 113.8, 80.9, 58.5, 55.3, 50.8, 44.1, 28.0; IR (thin film) υmax 
(cm-1): 1739 (s, C=O); HRMS (ESI): m/z 442.1006,
 
C21H26BrNNaO3 [M+Na]+ requires 442.0994. 
 
(R)-tert-Butyl 3-(2,4-dichlorophenyl)-3-((4-methoxybenzyl)-
amino)propanoate 6c 
(E)-tert-Butyl 3-(2,4-dichlorophenyl)acrylate 1c (0.45 g, 1.67 
mmol) was used to prepare the title compound as a yellow oil 
(0.52 g, 76% yield) using general procedure 2. []	 +24.1 (c 
1.58, CH2Cl2); 1H NMR (300 MHz, CDCl3) δH = 7.48 (1H, d, J = 
8.5 Hz, CHCHCCl), 7.29 (1H, d, J = 2.1 Hz, CClCHCCl), 7.19 
(1H, dd, J = 8.4 and 2.1 Hz, CHCHCCl), 7.09 (2H, d, J = 8.6 Hz, 
CHCHCOCH3), 6.75 (2H, d, J = 8.6 Hz, CHCHCOCH3), 4.44 
(1H, dd, J = 8.6 and 4.5 Hz, CHNH), 3.70 (3H, s, OCH3), 3.46 
(1H, d, J = 12.5 Hz, NHCHAHB), 3.41 (1H, d, J = 12.8 Hz, 
NHCHAHB), 2.51 (1H, dd, J = 15.6 and 4.7 Hz, CHACHBCO2), 
2.40 (1H, dd, J = 15.5 and 8.8 Hz, CHACHBCO2), 1.31 (9H, s, 
C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 170.6, 158.7, 138.5, 
134.2, 133.3, 129.4, 129.3, 127.5, 113.8, 81.0, 55.3, 55.1, 51.0, 
42.2, 28.1; IR (thin film) υmax (cm-1): 1723 (s, C=O); HRMS 
(ESI): m/z 432.1128,
 
C21H25Cl2NNaO3 [M+Na]+ requires 
432.1110. 
 
(R)-tert-Butyl 3-(4-cyanophenyl)-3-((4-methoxybenzyl)amino)-
propanoate 6d 
(E)-tert-Butyl 3-(4-cyanophenyl)acrylate 1d (0.23 g, 1 mmol) 
was used to prepare the title compound as a yellow oil (0.23 g, 
62% yield) using general procedure 2. []	
 +42.7 (c 3.35, 
EtOAc); 1H NMR (300 MHz, CDCl3) δH = 7.56 (2H, d, J = 8.4 
Hz, CHCHCCN), 7.42 (2H, d, J = 8.4 Hz, CHCHCCN), 7.07 
(2H, d, J = 8.6 Hz, CHCHCOCH3), 6.76 (2H, d, J = 8.6 Hz, 
CHCHCOCH3), 4.03 (1H, dd, J = 8.4 and 5.3 Hz, CHNH), 3.71 
(3H, s, OCH3), 3.46 (1H, d, J = 12.9 Hz, NHCHAHB), 3.38 (1H, 
d, J = 12.9 Hz, NHCHAHB), 2.53 (1H, dd, J = 15.4 and 8.3 Hz, 
CHACHBCO2), 2.41 (1H, dd, J = 15.4 and 5.4 Hz, CHACHBCO2), 
2.09 (1H, br. s, NH), 1.29 (9H, s, C(CH3)3); 13C NMR (75 MHz, 
CDCl3) δC = 170.4, 158.7, 148.5, 132.4, 131.8, 129.3, 128.2, 
118.9, 113.8, 111.2, 81.2, 58.8, 55.3, 50.9, 43.8, 28.0; IR (thin 
film) υmax (cm-1): 2226 (m, CN), 1703 (s, C=O); HRMS (ESI): 
m/z 389.1855,
 
C22H26N2NaO3 [M+Na]+ requires 389.1841. 
 
(R)-tert-Butyl 3-((4-methoxybenzyl)amino)-3-(4-nitrophenyl)-
propanoate 6e 
(E)-tert-Butyl 3-(4-nitrophenyl)acrylate 1e (0. 49 g, 2 mmol) was 
used to prepare the title compound as a yellow oil (0.33 g, 40% 
yield) using general procedure 2. []	
 +35.7 (c 2.6, EtOAc); 1H 
NMR (300 MHz, CDCl3) δH = 8.12 (2H, d, J = 8.7 Hz, 
CHCHCNO2), 7.47 (2H, d, J = 8.7 Hz, CHCHCNO2), 7.06 (2H, 
d, J = 8.5 Hz, CHCHCOCH3), 6.75 (2H, d, J = 8.5 Hz, 
CHCHCOCH3), 4.08 (1H, dd, J = 8.4 and 5.3 Hz, CHNH), 3.70 
(3H, s, OCH3), 3.46 (1H, d, J = 12.9 Hz, NHCHAHB), 3.38 (1H, 
d, J = 12.9 Hz, NHCHAHB), 2.53 (1H, dd, J = 15.4 and 8.4 Hz, 
CHACHBCO2), 2.42 (1H, dd, J = 15.4 and 5.3 Hz, CHACHBCO2), 
2.09 (1H, br. s, NH), 1.28 (9H, s, C(CH3)3); 13C NMR (75 MHz, 
CDCl3) δC = 170.4, 158.8, 150.7, 147.3, 131.8, 129.3, 128.3, 
123.8, 113.9, 81.3, 58.5, 55.3, 50.9, 43.7, 28.0; IR (thin film) υmax 
(cm-1): 1722 (s, C=O); HRMS (ESI): m/z 409.1777,
 
C21H26N2NaO5 [M+Na]+ requires 409.1739. 
 
(R)-tert-Butyl 3-((4-methoxybenzyl)amino)-3-(thiophen-2-yl)-
propanoate 6f 
(E)-tert-Butyl 3-(thiophen-2-yl)acrylate 1f (0.55 g, 2.61 mmol) 
was used to prepare the title compound as a colourless oil (0.78 
g, 86% yield) using general procedure 2. []	
 +23.5 (c 3.4, 
EtOAc); 1H NMR (300 MHz, CDCl3) δH = 7.19-7.12 (3H, m, 
CHCHCOCH3, CHS), 6.89-6.86 (2H, m, CHCHCS), 6.77 (2H, d, 
J = 8.6 Hz, CHCHCOCH3), 4.30 (1H, dd, J = 8.0 and 5.5 Hz, 
CHNH), 3.72 (3H, s, OCH3), 3.63 (1H, d, J = 12.8 Hz, 
NHCHAHB), 3.50 (1H, d, J = 12.9 Hz, NHCHAHB), 2.64 (1H, dd, 
J = 15.5 Hz, 8.3, CHACHBCO2), 2.56 (1H, dd, J = 15.4 and 5.5 
Hz, CHACHBCO2), 2.07 (1H, br. s, NH), 1.32 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.7, 158.6, 147.8, 132.2, 
129.5, 126.5, 124.5, 124.4, 113.8, 80.1, 55.3, 54.6, 50.6, 44.6, 
28.1; IR (thin film) υmax (cm-1): 1722 (s, C=O); HRMS (ESI): m/z 
370.1450,
 
C19H25NNaO3S [M+Na]+ requires 370.1453. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9 
(R)-tert-Butyl 3-(furan-2-yl)-3-((4-methoxybenzyl)amino)prop-
anoate 6g 
(E)-tert-Butyl 3-(furan-2-yl)acrylate 1g (0. 49 g, 2.57 mmol) was 
used to prepare the title compound as a yellow oil (0.62 g, 73% 
yield) using general procedure 2. []	
 +57.3 (c 3.3, EtOAc); 1H 
NMR (300 MHz, CDCl3) δH = 7.37 (1H, d, J = 1.9 Hz, CHO), 
7.21 (2H, d, J = 8.7 Hz, CHCHCOCH3), 6.84 (2H, d, J = 8.7 Hz, 
CHCHCOCH3), 6.32 (1H, dd, J = 3.1 and 1.9 Hz, CHCHO), 6.20 
(1H, d, J = 3.1 Hz, CHCHCHCO), 4.14 (1H, dd, J = 7.7 and 6.4 
Hz, CHNH), 3.79 (3H, s, OCH3), 3.68 (1H, d, J = 12.6 Hz, 
NHCHAHB), 3.54 (1H, d, J = 12.6 Hz, NHCHAHB), 2.18-2.01 
(2H, m, CH2CO2), 1.96 (1H, br. s, NH), 1.40 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.7, 158.6, 155.3, 141.7, 
132.2, 129.4, 113.7, 110.0, 106.8, 80.7, 55.3, 52.3, 50.5, 41.1, 
28.0; IR (thin film) υmax (cm-1): 1725 (s, C=O); HRMS (ESI): m/z 
354.1691,
 
C19H25NNaO4 [M+Na]+ requires 354.1681. 
 
(R)-tert-Butyl 3-((4-methoxybenzyl)amino)heptanoate 6h 
(E)-tert-Butyl hept-2-enoate 1h (1.01 g, 5.5 mmol) was used to 
prepare the title compound as a yellow oil (1.2 g, 68% yield) 
using general procedure 2. []	
 -3.5 (c 2.02, CH2Cl2); 1H NMR 
(300 MHz, CDCl3) δH = 7.20 (2H, d, J = 8.6 Hz, CHCHCOCH3), 
6.80 (2H, d, J = 8.6 Hz, CHCHCOCH3), 3.72 (3H, s, OCH3), 
3.65 (2H, s, NHCH2), 2.90 (1H, quintet, J = 6.1 Hz, CHNH), 2.29 
(2H, d, J = 6.1 Hz, CH2CO2), 1.65 (1H, br. s, NH), 1.37 (9H, s, 
C(CH3)3), 1.30-1.14 (6H, m, CH3CH2CH2CH2), 0.82 (3H, t, J = 
7.2 Hz, CH3CH2); 13C NMR (75 MHz, CDCl3) δC = 172.4, 158.9, 
133.1, 129.7, 114.1, 80.8, 55.7, 54.8, 50.8, 40.8, 34.4, 28.5, 28.3, 
23.2, 14.4; IR (thin film) υmax (cm-1): 1722 (s, C=O); HRMS 
(ESI): m/z 322.2377,
 
C19H32NO3 [M+H]+ requires 322.2381. 
 
(R,E)-tert-Butyl 3-((4-methoxybenzylidene)amino)-3-phenyl-
propanoate 15a 
Cerium ammonium nitrate (1.72 g, 2.94 mmol) was added to a 
solution of (R)-tert-Butyl 3-((4-methoxybenzyl)amino)-3-
phenylpropanoate 6a (0.251 g, 0.736 mmol) in MeCN-H2O (5:1, 
9.4 mL) and the bright orange solution stirred at room 
temperature for 2 hours, before saturated NaHCO3(aq) (50 mL) 
was added. The mixture was partitioned between brine and Et2O 
and the aqueous layer further extracted with Et2O (2 x 20 mL). 
The combined organic extracts were dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to afford the title 
compound as a yellow oil (0.204 g, 82% yield). []	 -30.0 (c 
2.9, CH2Cl2); 1H NMR (300 MHz, CDCl3) δH = 8.36 (1H, s, 
CH=N), 7.76 (2H, d, J = 8.5 Hz, CHCHCOCH3), 7.50 (2H, d, J = 
7.7 Hz, Ph), 7.41- 7.36 (2H, m, Ph), 7.32-7.27 (1H, m, Ph), 6.96 
(2H, d, J = 8.5 Hz, CHCHCOCH3), 4.82 (1H, dd, J = 9.5 and 4.9 
Hz, CHN=CH), 3.89 (3H, s, OCH3), 2.97 (1H, dd, J = 15.0 and 
1.5 Hz, CHAHB), 2.86 (1H, dd, J = 14.9 and 4.8 Hz, CHAHB), 
1.39 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 170.7, 
161.7, 160.5, 143.1, 130.1, 129.2, 128.5, 127.2, 127.0, 113.9, 
80.6, 71.4, 55.4, 44.8, 28.1; IR (thin film) υmax (cm-1): 1723 (s, 
C=O); HRMS (ESI): m/z 362.1754,
 
C21H25NNaO3 [M+Na]+ 
requires 362.1732. 
 
General Procedure 3: Oxidative deprotection of tert-butyl N-
PMB-β-amino esters 6a-h 
Cerium ammonium nitrate (4 eq.) was added to a solution of the 
appropriate N-PMB-β-amino ester 6 (1 eq.) in MeCN-H2O (5:1, 
0.2 M) and the bright orange solution stirred at room temperature 
for 2 hours before saturated NaHCO3(aq) (50 mL) was added. 
The mixture was partitioned between brine and Et2O and the 
aqueous layer further extracted with Et2O (2 x 20 mL). The 
combined organic extracts were dried over anhydrous MgSO4, 
filtered and concentrated in vacuo. The resultant crude product 
was dissolved in MeCN-H2O (5:1, 0.2 M), acetic acid (15 eq.) 
was then added and the reaction mixture stirred at room 
temperature for 48 hours. The reaction mixture was then diluted 
with water (5mL) and washed with Et2O (3 x 10 mL). The 
aqueous layer was basified with saturated NaHCO3(aq), extracted 
with Et2O (3 x 20 mL), and the combined organic extracts dried 
(MgSO4), filtered and concentrated in vacuo to afford a crude 
product that was purified by chromatography to afford the 
desired tert-butyl β-amino ester 5a-h. 
 
(R)-tert-Butyl 3-amino-3-phenylpropanoate 5a 
N-PMB-β-amino ester 6a (0.1 g, 0.3 mmol) was used to prepare 
the title compound as a yellow oil (0.044 g, 68% yield) using 
general procedure 3. []	 +20.0 (c 1.2, CHCl3) (Lit.29 []	 
+19.7 (c 0.96, CHCl3); 1H NMR (300 MHz, CDCl3) δH = 7.15-
7.33 (5H, m, Ph), 4.31 (1H, t, J = 6.9 Hz, CHNH), 2.52 (2H, d, J 
= 7.0 Hz, CH2CO2), 2.41 (2H, br. s, NH2), 1.35 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 171.4, 145.4, 128.5, 127.3, 
126.3, 80.7, 52.8, 45.4, 28.1; IR (thin film) υmax (cm-1): 3312 (w, 
N-H), 1725 (s, C=O); HRMS (ESI): m/z 222.1500,
 
C13H20NO2 
[M+H]+ requires 222.1489. 
 
(R)-tert-Butyl 3-amino-3-(4-bromophenyl)propanoate 5b 
N-PMB-β-amino ester 6b (0.19 g, 0.46 mmol) was used to 
prepare the title compound as a colourless oil (0.077 g, 56% 
yield) using general procedure 3. []	 +21.7 (c 0.92, CDCl3); 1H 
NMR (300 MHz, CDCl3) δH = 7.37 (2H, d, J = 8.5 Hz, 
CHCHCBr), 7.17 (2H, d, J = 8.5 Hz, CHCHCBr), 4.29 (1H, br. s, 
CHNH2), 2.47 (2H, d, J = 6.7 Hz, CH2CO2), 1.76 (2H, br. s, 
NH2), 1.34 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 
171.0, 143.7, 131.6, 128.2, 121.0, 81.0, 52.2, 45.1, 28.1; IR (thin 
film) υmax (cm-1): 3662 (m, N-H), 3376 (w, N-H), 1722 (s, C=O); 
HRMS (ESI): m/z 300.0620,
 
C13H19BrNO2 [M+H]+ requires 
300.0599. 
 
(R)-tert-Butyl 3-amino-3-(2,4-dichlorophenyl)propanoate 5c 
N-PMB-β-amino ester 6c (0.14 g, 0.33 mmol) was used to 
prepare the title compound as a yellow oil (0.066 g, 68% yield) 
using general procedure 3. []	 +37.6 (c 0.85, CDCl3); 1H NMR 
(300 MHz, CDCl3) δH = 7.44 (1H, d, J = 8.4 Hz, CHCHCCl), 
7.20 (1H, d, J = 1.8 Hz, CClCHCCl), 7.8 (1H, dd, J = 8.4 and 1.9 
Hz, CClCHCH), 4.70 (1H, br. s, CHNH2), 2.60 (1H, dd, J = 16.0 
and 4.0 Hz, NHCHAHB), 2.44 (1H, dd, J = 16.0 and 9.0 Hz, 
NHCHAHB), 2.29 (2H, br. s, NH2), 1.36 (9H, s, C(CH3)3); 13C 
NMR (75 MHz, CDCl3) δC = 170.8, 136.4, 133.4, 133.3, 129.4, 
128.4, 127.5, 81.2, 48.7, 42.8, 28.1; IR (thin film) υmax  (cm-1): 
3383 (w, N-H), 1725 (s, C=O); HRMS (ESI): m/z 312.0525,
 
C13H17Cl2NNaO2 [M+Na]+ requires 312.0534. 
 
(R)-tert-Butyl 3-amino-3-(4-cyanophenyl)propanoate 5d 
N-PMB-β-amino ester 6d (0.16 g, 0.45 mmol) was used to 
prepare the title compound as a yellow oil (0.057 g, 51% yield) 
using general procedure 3. []	 +16.0 (c 0.5, CDCl3); 1H NMR 
(300 MHz, CDCl3) δH = 7.68 (2H, d, J = 8.0 Hz, CHCHCCN), 
7.55 (2H, d, J = 8.0 Hz, CHCHCCN), 4.50 (1H, br. s, CHNH2), 
2.63 (2H, d, J = 6.6 Hz, CH2CO2), 2.14 (2H, br. s, NH2), 1.46 
(9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 171.6, 145.2, 
132.4, 127.3, 118.8, 111.3, 81.3, 52.5, 44.8, 28.1; IR (thin film) 
υmax (cm-1): 2228 (m, CN), 1723 (s, C=O); HRMS (ESI): m/z 
247.1448,
 
C14H19N2O2 [M+H]+ requires 247.1447. 
 
(R)-tert-Butyl 3-amino-3-(4-nitrophenyl)propanoate 5e 
N-PMB-β-amino ester 6e (0.13 g, 0.33 mmol) was used to 
prepare the title compound as a yellow oil (0.057 g, 65% yield) 
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using general procedure 3. []	 +9.1 (c 0.55, CDCl3); 1H 
NMR (300 MHz, CDCl3) δH = 8.11 (2H, d, J = 8.9 Hz, 
CHCHCNO2), 7.49 (2H, d, J = 8.6 Hz, CHCHCNO2), 4.42 (1H, 
br. s, CHNH2), 2.51 (2H, d, J = 6.7 Hz, CH2CO2), 1.78 (2H, br. s, 
NH2), 1.34 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 
170.6, 152.2, 147.2, 127.4, 123.8, 81.3, 52.3, 45.0, 28.1; IR (thin 
film) υmax (cm-1): 3382 (w, N-H), 1720 (s, C=O); HRMS (ESI): 
m/z 289.1156,
 
C13H18N2NaO4 [M+Na]+ requires 289.1164. 
 
(R)-tert-Butyl 3-amino-3-(thien-2-yl)propanoate 5f 
N-PMB-β-amino ester 6f (0.2 g, 0.59 mmol) was used to prepare 
the title compound as a yellow oil (0.048 g, 36% yield) using 
general procedure 3. []	 +18.2 (c 0.44, CDCl3); 1H NMR (300 
MHz, CDCl3) δH = 7.27 (1H, dd, J = 1.7 and 0.7 Hz, CHS), 6.23 
(1H, dd, J = 3.1 and 1.8 Hz, CHCHCS), 6.09 (1H, d, J = 3.2 Hz, 
CHCCS), 4.31 (1H, dd, J = 8.3 and 4.9 Hz, CHNH), 2.68 (1H, 
dd, J = 15.8 and 5.0 Hz, CHAHBCO2), 2.55 (1H, dd, J = 15.4 and 
8.4 Hz, CHACHBCO2), 2.34 (1H, br. s, NH2), 1.3 (9H, s, 
C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 170.8, 136.9, 128.6, 
128.1, 127.1, 81.0, 46.8, 42.1, 28.1; IR (thin film) υmax (cm-1): 
1727 (s, C=O); HRMS (ESI): m/z 228.1078,
 
C11H18NO2S [M+H]+ 
requires 228.1058. 
 
(R)-tert-Butyl 3-amino-3-(furan-2-yl)propanoate 5g38 
N-PMB-β-amino ester 6g (0.1 g, 0.31 mmol) was used to prepare 
the title compound as a pale green oil (0.048 g, 73% yield) using 
general procedure 3. []	 +12.4 (c 1.05, CDCl3); 1H NMR (300 
MHz, CDCl3) δH = 7.12 (1H, dd, J = 4.5 and 1.9 Hz, CHCHO), 
6.89-6.84 (2H, m, CHOCCH), 4.58 (1H, dd, J = 8.4 and 4.9 Hz, 
CHNH2), 2.65 (1H, dd, J = 15.9 and 4.9 Hz, CHAHBCO2), 2.57 
(1H, dd, J = 15.9 and 8.4 Hz, CHAHBCO2), 2.22 (2H, br. s, NH2), 
1.36 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 170.8, 
144.0, 142.6, 124.0, 110.2, 81.0, 48.7, 45.6, 28.1; IR (thin film) 
υmax (cm-1): 3385 (w, N-H), 1723 (s, C=O); HRMS (ESI): m/z 
212.1286,
 
C11H18NO3 [M+H]+ requires 212.1287. 
 
(R)-tert-Butyl 3-aminoheptanoate 5h 
N-PMB-β-amino ester 6h (0.21 g, 0.66 mmol) was used to 
prepare the title compound as a colourless oil (0.089 g, 60% 
yield) using general procedure 3. []	 +33.3 (c 1.2, CDCl3); 1H 
NMR (300 MHz, CDCl3) δH = 3.13-3.00 (1H, m, CHNH2), 2.31 
(1H, dd, J = 15.6 and 4.0 Hz, CHAHBCO2), 2.10 (1H, dd, J = 15.6 
and 8.8 Hz, CHAHBCO2), 1.61 (2H, br. s, NH2), 1.39 (9H, s, 
C(CH3)3), 1.36-1.19 (6H, m, CH2CH2CH2CH3), 0.83 (3H, t, J = 
6.3 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δC = 172.1, 80.5, 
48.4, 43.8, 37.2, 28.2, 28.1, 22.7, 14.0; IR (thin film) υmax (cm-1): 
3385 (w, N-H), 1723 (s, C=O); HRMS (ESI): m/z 202.1801,
 
C11H24NO2 [M+H]+ requires 202.1807.  
 
General Procedure 4: Determination of the Enantiomeric 
Excess of (R)-tert-butyl β-Amino Esters.36b 
Each (R)-tert-butyl β-amino ester (1 eq.) and K2CO3 (1.1 eq.) 
were suspended in a minimum amount of CDCl3. 2-Formyl-
phenylboronic acid (1.1 eq.), (R)-(BINOL) (1.1 eq.), 4 Å 
molecular sieves, and CDCl3 were then added in order to produce 
a 0.1 M solution of the β-amino ester. The solution was stirred 
for 10 min before being filtered through a small pad of Celite and 
the solution analyzed by 1H NMR spectroscopy. 
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